Healthtech & Wellness VC Funds

Alix Ventures is a venture capital firm dedicated to supporting early-stage life science startups, particularly those driving advancements in human health through the innovative fusion of technology and biology, often referred to as "TechBio." Founded by a team of experienced life science entrepreneurs, Alix Ventures aims to partner with founders who possess unique insights and the ambition to tackle some of the most pressing challenges in healthcare. The firm focuses on companies that are engineering biology to create transformative solutions, with a portfolio that includes startups like Xilis, Elegen, and Endpoint Health. These companies are at the forefront of developing technologies that enable precision medicine, advanced DNA writing, and immunology. Alix Ventures operates primarily out of San Francisco and Boston, but they also have a presence in other U.S. cities. They are known for their strong support network, providing not just capital but also valuable connections to industry experts, follow-on VCs, and key opinion leaders in pharma and healthcare. The firm’s advisory board comprises PhD-level bioengineers and industry veterans, ensuring deep technical diligence across a broad spectrum of life science sub-domains. With a strong commitment to driving patient impact, Alix Ventures continues to support breakthrough innovations that push the boundaries of what's possible in life sciences.

AI2 Incubator, founded by Paul Allen's Allen Institute for AI, is a Seattle-based incubator focused on launching groundbreaking AI startups. With a mission to support AI-driven innovation, AI2 Incubator provides pre-seed investments of up to $500,000, access to $1M in cloud computing credits, and AI product development resources. Startups in its portfolio span critical areas like foundation models, AI for social good, and domain-specific AI. Some of their notable alumni include companies like Lexion, WhyLabs, and WellSaid Labs, with the incubator's startups collectively raising over $220 million. AI2 Incubator emphasizes hands-on involvement, supporting founders from ideation through Series A. It also offers extensive technical guidance, customer discovery assistance, and access to a network of AI experts. Founders from diverse backgrounds—engineers, scientists, product leaders—are encouraged to apply, with the incubator prioritizing teams that are passionate about solving real-world problems through AI. The incubator is led by a team of seasoned AI professionals, including Oren Etzioni and Jacob Colker, who work closely with startups to ensure their success in building innovative products and scaling their businesses. With deep ties to the AI2 research institute, AI2 Incubator helps startups leverage cutting-edge research to build impactful, scalable products. This unique combination of early capital, expert mentorship, and technical support has made AI2 Incubator a key player in fostering the next generation of AI-first companies.

Alley Robotics Ventures (ARV) is a cutting-edge venture capital fund dedicated to advancing the fields of robotics and automation. Launched with a $30 million Fund I, ARV aims to back and incubate startups that are revolutionizing industries through robotics technology. The fund is supported by prominent investors such as Kevin Ryan, founder of AlleyCorp, and Eliot Horowitz, founder of Viam Robotics. These anchor investors bring deep operational expertise and a track record of successful company-building, giving ARV a strong foundation. ARV focuses on early-stage investments, targeting innovative solutions in both hardware and software within the robotics sector. Their portfolio already includes promising startups like Aescape, which specializes in robotic massage technology, Civ Robotics, a leader in autonomous surveying, and Dexai Robotics, known for its robotic kitchen assistant technology. The fund’s strategic approach is heavily influenced by the AlleyCorp model, which emphasizes flexibility in creating and supporting new ventures. Leading ARV is Abe Murray, who brings significant experience from his previous roles at Alphabet and AlleyCorp. Murray has a background in product and engineering leadership, having worked on major projects like Android and Google Research. This deep technical and strategic expertise enables ARV to effectively identify and nurture groundbreaking technologies that have the potential to transform industries. ARV is not just an investor but a true partner to its portfolio companies, offering hands-on support and leveraging its extensive network to drive growth and innovation in the rapidly expanding robotics and automation sectors​.

AlleyCorp, founded by New York internet entrepreneur Kevin Ryan, is both a startup studio and venture capital fund. The firm is known for launching and investing in transformative companies primarily in New York City. AlleyCorp is responsible for building some of New York’s most iconic tech companies, including MongoDB, Business Insider, Gilt Groupe, Zola, and Nomad Health. The firm operates across several dedicated verticals: Diversified Technology, Healthcare, Robotics, and Economic Infrastructure. They are highly active in the early stages of investment, focusing mainly on pre-seed and seed rounds, often being the first check in. They also make select Series A investments. AlleyCorp takes a hands-on approach by originating ideas, hiring teams, providing initial funding, and maintaining leadership throughout the company's lifecycle. Their portfolio includes notable startups such as Affect Therapeutics, RippleMatch, and Properly, covering diverse industries from digital health to real estate technology. The firm’s strategy is characterized by deep involvement and long-term partnership with its portfolio companies, supporting them from inception through to potential IPOs. AlleyCorp’s team is composed of seasoned startup operators and investors, including General Partners like Jay Hass and Marshall Porter, and specialists like Brenton Fargnoli, MD, in healthcare investments. This robust team ensures that the companies they back have the support and resources needed to thrive.

Alliance of Angels, founded in 1997, is the largest and most active angel group in the Pacific Northwest. Based in Seattle, AoA comprises over 180 accredited investors who collectively invest more than $10 million annually into around 20 startups. The group primarily focuses on high-growth companies in technology, hardware, consumer products, and life sciences sectors. AoA has generated over $1 billion in returns from exits, with notable successes including DocuSign, Elemental Technologies, and BuddyTV. AoA's investment process begins with an introductory meeting, followed by a screening committee review, a member meeting presentation, and a due diligence phase. They typically invest between $500,000 to $2.5 million in seed and early-stage rounds, often co-investing with other angel groups and venture funds. The Alliance of Angels Innovation Fund, an annual fund, provides additional capital with quick decision-making processes. AoA's portfolio features diverse investments such as Proton Intelligence, Anuncia Medical, Phase Genomics, and Olis Robotics. They support startups from Washington, Oregon, Idaho, Montana, British Columbia, and Alaska, though they also consider opportunities across the US and Canada.

Allianz Life Ventures is the corporate venture capital arm of Allianz Life Insurance Company of North America, founded in 2016 and based in Minneapolis, Minnesota. Operating as a $175 million evergreen fund, the firm invests in insurtech, fintech, wealthtech, capital markets technology, enterprise SaaS, and digital health companies that are transforming the insurance landscape through technology and novel business models. As part of Allianz SE — one of the world's largest insurance and asset management companies — the fund provides portfolio startups with deep industry expertise and access to a global distribution network spanning advisory channels, employer markets, and retiree services. The fund makes Series A and Series B investments with typical initial checks of $3 million to $5 million, and has completed 24 direct investments to date. Notable portfolio companies include Accern (AI development platform for financial services), Advizr (financial planning software), Blaise (AI-powered insurance operations), Blooom (online investment advisor), and Covr (digital life insurance distribution platform). Allianz Life Ventures targets startups with at least $1 million in annual recurring revenue, seeking companies with demonstrated commercial traction before backing them with growth capital. The investment thesis centres on identifying businesses that will shape the future of life insurance, employer benefits, and retirement services — areas where Allianz Life has established commercial relationships that can directly accelerate the growth of portfolio companies in the US market and beyond.

Allianz X, the digital investment arm of Allianz Group, focuses on investing in digital growth companies relevant to insurance and asset management. Since its inception, Allianz X has grown its portfolio to over 25 companies with assets under management exceeding €2 billion. The firm has identified 12 unicorns within its portfolio, showcasing its strategic investment acumen. Headquartered in Munich, Allianz X supports companies primarily in the insurtech and fintech sectors, aiming to foster innovations that complement Allianz Group's core businesses. Their investment approach includes late-stage funding, helping mature companies reach their next growth milestones. Key portfolio companies include WeLab, a leading digital financial service provider in Asia, and Pie Insurance, a digital provider of workers' compensation insurance in the U.S. Allianz X has been involved in significant funding rounds, such as co-leading a $250 million Series F investment in Coalition, Inc., a cyber insurtech company, and leading funding for London-based fintech OpenGamma. Their strategy also includes facilitating collaborative partnerships within the digital ecosystem to drive innovation and growth​.

Allos Ventures, based in Indianapolis, Indiana, focuses on investing in early-stage B2B software and tech-enabled service companies, primarily within the Midwest. The firm, co-founded by Don Aquilano, John McIlwraith, and David Kerr, emphasizes a hands-on approach, leveraging over fifty years of combined experience to support the growth of high-tech companies​. Allos Ventures recently closed its fourth fund, Allos IV, aiming to invest $75 million in promising startups. This fund continues the firm's strategy of backing high-growth software companies in the Midwest, building on successful investments in companies like Lessonly, Assurex Health, and Authenticx​. The firm prefers to lead or co-lead investment rounds, providing initial checks ranging from $500K to $10M. They focus on Series A and B investments in companies that have an existing product or service generating revenue but are still a few years away from profitability. Notable portfolio companies include 120Water, Encamp, and Aware, among others. Allos Ventures is known for its commitment to the Midwest entrepreneurial ecosystem, supporting founders with deep industry expertise and helping them scale rapidly by attracting top talent from across the country.

Harvard Innovation Labs (i-lab) stands out as a leading incubator and accelerator for startups, with a significant portfolio of impactful ventures. Notable investments include Manifold Bio, which raised $40 million to advance its biologics discovery platform, and Akouos, a gene therapy company acquired by Eli Lilly for over $600 million. Focusing on diverse industries such as biotechnology, edtech, and sustainability, i-lab supports ventures like BioDevek in medical devices and Earthbond in renewable energy. Geographically, their impact spans globally, benefiting startups from the U.S. to Vietnam. i-lab’s strategy centers on providing comprehensive support through programs like Launch Lab X GEO, offering resources for early-stage ventures to grow sustainably. The fund emphasizes collaboration, preferring to lead rounds and actively engaging in the growth journey of their startups. They typically offer pre-seed funding ranging from $10,000 to $100,000, focusing on high-potential, high-impact ventures. Key figures at i-lab include Jodi Goldstein, the Executive Director, who brings extensive experience in entrepreneurship and innovation. The team is based in Cambridge, MA, leveraging Harvard’s vast network and resources. For startups, approaching i-lab requires demonstrating innovative solutions with clear market potential. The fund values ventures that address significant challenges and show strong potential for scalability and impact.

Almaz Capital is a venture capital firm founded in 2008 by Alexander Galitsky, focusing on early-stage technology startups with global market potential. With offices in Silicon Valley and Berlin, Almaz Capital bridges entrepreneurial talent from Central and Eastern Europe (CEE) and the Commonwealth of Independent States (CIS) with global markets. The firm has invested in notable companies like Acumatica, Vyatta, Parallels, and EverNote. The firm targets sectors such as Internet Infrastructure, Software, Artificial Intelligence, and Internet of Things (IoT). They are known for supporting companies through various growth stages, providing not just capital but also strategic guidance, industry connections, and operational support. Almaz Capital is committed to fostering innovation and scalability in its portfolio companies. Key team members include Alexander Galitsky (Co-Founder and Managing Partner), Charles E. Ryan (General Partner), and Geoffrey Baehr (General Partner). The team brings extensive experience in global business operations and investment, helping startups achieve significant growth and market reach.

Almi Invest is Sweden's most active early-stage venture capital firm, focusing on investing in startups across various sectors, including technology, life sciences, industry, and cleantech. As part of the state-owned Almi Group, Almi Invest operates through eight regional funds and a specialized national GreenTech fund, which targets climate-smart investments that contribute to CO2 reduction. The firm has recently raised €140 million (approximately SEK 1.6 billion) for its third investment fund, which will be deployed from 2024 to 2029. This fund aims to support around 300 startups, continuing Almi's tradition of nurturing early-stage companies across Sweden. Over its history, Almi Invest has backed nearly a thousand companies, achieving over 600 successful exits. This track record has established the firm as a cornerstone of Sweden's startup ecosystem, with many portfolio companies eventually being acquired by global giants like Google, Microsoft, and Apple. Almi Invest's regional presence is critical to its strategy, ensuring that startups throughout Sweden have access to the capital and support they need to grow. The firm’s focus on sustainability and innovation aligns with Sweden’s broader goals of fostering a vibrant, future-oriented economy.

Aloft VC, led by Crystal McKellar, invests in early-stage technology companies addressing critical challenges in healthcare, national security, and fintech. Some standout portfolio companies include Vannevar Labs (national security tech), Angle Health (AI-enabled healthcare), and Cooler Heads (FDA-approved cancer care devices). The firm has a sharp focus on national security and defense tech, leveraging Crystal’s deep connections from her work with Peter Thiel and Palantir. Aloft typically participates in early-stage rounds and often leads investments, as seen with Cooler Heads. The average check size is flexible depending on the round, but the firm actively builds its pipeline through founder referrals and strategic partnerships in Silicon Valley’s defense and healthcare circles. Startups that align with Aloft’s mission to solve high-impact, systemic problems in its focus sectors are encouraged to approach them with well-developed technology solutions and clear market differentiation. McKellar’s experience spans law and venture capital, with notable prior investments in companies like Palantir and Siren Care. Based in San Francisco, Aloft VC maintains a tight-knit network of experts in tech and defense, offering founders more than just capital—strategic insights and meaningful introductions to fuel growth.

Alon MedTech Ventures is a leading venture capital firm based in Israel, focusing on the incubation and growth of early-stage medical device companies. Founded and chaired by Dr. Shimon Eckhouse, a well-known inventor and entrepreneur in the medical technology sector, Alon MedTech plays a critical role in advancing innovative healthcare solutions that aim to improve global well-being. The firm operates as part of Israel’s Innovation Authority incubator system, providing startups with not only financial backing but also strategic guidance, access to state-of-the-art facilities, and industry expertise. Alon MedTech's investment strategy emphasizes novel technologies that have the potential to revolutionize medical practices and patient outcomes. Alon MedTech’s portfolio includes a variety of groundbreaking companies, such as Hallura, which is developing next-generation hyaluronic acid dermal fillers using a unique crosslinking technology, and SofWave, which offers non-invasive skin tightening solutions using ultrasound technology. The firm’s approach is highly hands-on, working closely with entrepreneurs from the ideation stage through to commercialization, ensuring that these companies can scale successfully and impact the healthcare industry globally. The firm’s commitment to innovation and deep engagement with portfolio companies has positioned it as a key player in the medical device sector, particularly within Israel’s vibrant tech ecosystem.

Alpaca VC is a dynamic seed-stage venture capital firm headquartered in New York, known for its unique approach of investing at the intersection of the physical and digital worlds. Founded by experienced entrepreneurs, Alpaca VC focuses on transforming traditional industries through technology. Their notable investments include Minibar Delivery, ClassPass, and Transfix, reflecting their diverse portfolio in sectors such as proptech, marketplaces, and e-commerce. Alpaca VC primarily targets investments in North America, with a strong emphasis on real estate and commerce startups. They follow a thematic, research-driven strategy, leveraging their extensive network and firsthand experience to support founders. The average investment size ranges from $1 million to $2 million, and they often lead seed rounds​. The firm is led by a team of seasoned professionals, including General Partners Daniel Fetner and David Goldberg, who bring deep expertise from their entrepreneurial and investment banking backgrounds. This leadership team is committed to providing hands-on support and strategic guidance to their portfolio companies. For startups looking to engage with Alpaca VC, the firm values founders who are tackling non-obvious markets with innovative solutions. They prefer to build long-term relationships, offering not just capital but also valuable industry connections and operational support. Alpaca VC is known for its rigorous selection process and high level of engagement with its investments, ensuring that they can significantly contribute to each startup’s growth and success​.

Alpana Ventures is a Swiss-based venture capital firm that focuses on deep tech and digital transformation, primarily investing in startups in Switzerland, Europe, and the U.S. Their portfolio spans across various innovative sectors, including healthcare, fintech, real estate, and AI. Some of their notable investments include Lunaphore (cancer diagnostic tech), Inpher (privacy-preserving AI solutions), and DomoHealth (remote monitoring for elderly care). Alpana Ventures typically supports early-stage startups with scalable and disruptive technologies. They prioritize companies with high growth potential that are at the intersection of deep tech and sustainability. Their team offers more than just capital—providing strategic guidance, a global network, and hands-on operational support. Key team members include Christophe Chemtob, Pascal Widmer, and Hervé Liboureau, each with decades of experience in investments and entrepreneurship. The firm operates out of Geneva and Sion, with a focus on helping companies grow and scale in global markets. Alpana’s impact-driven approach also extends to sectors like cleantech, where they actively seek solutions that contribute to a sustainable future​.

Alpha Bridge Ventures is an early-stage venture capital fund based in San Francisco, specializing in seed investments and founder development. The firm was founded by Howie Diamond and Jake Chapman, with a mission to support both the professional and personal growth of founders to ensure the long-term success of their startups. Alpha Bridge emphasizes mental health and well-being, believing that healthy founders lead to healthy companies. Their investment strategy targets innovative sectors such as alternative proteins, future-of-work platforms, functional beverages, and sustainable technologies. Notable portfolio companies include Alpha Foods, Nana, MudWtr, Living Carbon, Roam Research, and SquadApp. Alpha Bridge Ventures provides extensive support through an integrated founder development program. This program includes executive coaching, physical health optimization, and emotional fitness resources, aiming to reduce founder burnout and improve overall resilience and performance. The firm’s approach is data-driven, starting with comprehensive self-assessments for founders to identify areas for improvement. This holistic support model has been lauded by industry professionals as a much-needed resource for startup founders. For startups seeking funding, Alpha Bridge looks for innovative ideas with strong market potential and values founders who prioritize personal growth alongside business development.

Alpha Edison, based in Los Angeles, is a venture capital firm that partners with early-stage entrepreneurs to build category-defining companies. Founded in 2016 by Michael Parekh, Alpha Edison focuses on investing in technology-driven sectors such as software, data and behavioral science, artificial intelligence, and machine learning. Notable investments by Alpha Edison include Comparably, Rize, Brainbase, and Greenfly. These investments highlight their commitment to fostering innovative solutions across various industries​​. The firm's investment strategy centers on identifying latent demand and supporting founders in unlocking new markets, with an emphasis on leveraging technology to drive growth and transformation. Alpha Edison typically engages at the Series A and B stages, providing substantial operational support and strategic guidance to help scale businesses effectively. Their approach is characterized by a deep understanding of market behaviors and a focus on data-driven insights to ensure sustainable growth and market impact​. The team at Alpha Edison includes experienced partners like Britt Danneman, Robey Miller, and Steve Horowitz, who bring diverse expertise in investment and entrepreneurial support. This cognitively diverse team is dedicated to helping founders navigate the complexities of scaling their businesses and achieving long-term success.

AI Capital is a venture capital firm based in Denver, with operations spanning North America, Europe, and Asia. It focuses on early-stage investments in AI-driven companies, particularly in enterprise software and data platforms. The firm’s primary industry targets are healthcare, life sciences, and core industries like energy and manufacturing, where AI can optimize supply chains and critical services. Additionally, AI Capital invests heavily in cybersecurity, recognizing its importance across these sectors. The firm typically invests in Seed to Series B rounds, bringing a strong combination of technical expertise and deep investment experience. Recent notable portfolio companies include Link3D, Syndesis Health, and Luminoso. AI Capital emphasizes transformative AI applications, from VR therapy to advanced genomic solutions. They aim to support companies with high growth potential and significant societal impact. The firm is led by experienced partners like Neville Teagarden and Andrew Maus, with a team composed of AI specialists and seasoned investors. They value companies solving real-world problems through breakthrough AI technologies. AI Capital often leads rounds and is known for being highly involved with its portfolio companies, offering both strategic and operational support. Founders are encouraged to approach them through established networks or referrals, particularly those innovating in AI's frontier sectors.

Alpha JWC Ventures is one of Southeast Asia's leading venture capital firms, based in Jakarta, Indonesia and founded in 2015 by co-founders and General Partners Jefrey Joe and Chandra Tjan. With $650 million in assets under management and more than 70 active portfolio companies, the firm is among the largest early-stage VCs in the region. Fund III, which closed at $433 million, was the largest VC fund for early-stage startups in Southeast Asia at the time of its closing. The firm also operates A-Ventures for growth-stage investments, giving it a multi-stage presence across the Indonesian and broader regional ecosystem. Alpha JWC leads seed, Series A, and Series B rounds, deploying $1 million to $30 million with an initial check range of $1 million to $5 million and a 3-to-5-year investment horizon. Focus sectors include fintech, consumer goods, food and beverage, healthcare, education, fashion, real estate, and transportation. At least 11 portfolio companies are approaching unicorn status. Notable investments include Kopi Kenangan (coffee chain), GudangAda (B2B marketplace), Lemonilo (consumer goods), and Funding Societies (SME digital financing). Institutional LPs span Asia, the US, and Europe. The firm delivers hands-on value creation to portfolio companies — building networks, supporting marketing and talent acquisition, navigating government relations, and developing strategic partnerships across Southeast Asia's complex multi-market environment. Alpha JWC takes a long-term perspective on company building, aligning its support with the conviction that Southeast Asia's expanding middle class and digital penetration create durable, generational opportunities for technology founders with regional ambition.

Alt Capital is a venture capital firm founded in 2011 and headquartered in San Francisco. The firm primarily focuses on early-stage investments, specifically Seed and Series A rounds, in high-tech sectors such as enterprise applications, healthtech, and other disruptive technologies. Alt Capital is committed to identifying high-growth potential companies that are poised to innovate within their industries. The firm has made several notable investments, including Eden, a healthtech company in Mexico, and Foundation Health in the U.S., showcasing its international reach across the United States, Mexico, and Spain. With a flexible investment range, Alt Capital typically invests between $25,000 and $500,000 per deal. The firm has an emphasis on supporting startups that demonstrate scalability and strong technological innovation. Led by Bala Chandrasekaran and Jack Altman, Alt Capital takes a hands-on approach, helping its portfolio companies grow and develop through strategic guidance and capital support.

Altair Capital, founded in 2005 by Igor Ryabenkiy, is a prominent venture capital firm headquartered in San Francisco. The firm specializes in early-stage and growth-stage investments, focusing on sectors such as productivity tools, fintech, insurtech, artificial intelligence, digital health, and future of work technologies. With over $600 million in assets under management, Altair Capital has invested in more than 300 tech startups globally, including notable unicorns like Miro, Deel, PandaDoc, OpenWeb, Socure, Turing, Verbit, Sunbit, Albert, and Jeeves. Altair Capital emphasizes supporting innovative and disruptive ideas that have strong product vision, scalable business models, and large market potential. The firm is known for its hands-on approach, providing strategic guidance and resources to help startups achieve significant growth and success. The firm has achieved numerous successful exits, including companies like GBooking, ADEx Document Intelligence, and REZI. Altair Capital also offers private investors the opportunity to invest in promising startups through their platform, AltaClub, allowing individuals to benefit from the same deal conditions as the firm. Altair Capital operates with a global perspective, actively investing in the US, Europe, and Israel, and has a track record of fostering high-growth companies that tackle significant market challenges and opportunities.

Altimeter Capital is a prominent investment firm with a focus on technology-driven companies across both public and private markets. Founded by Brad Gerstner in 2008, the firm is headquartered in Boston, Massachusetts, with a significant presence in Menlo Park, California. Altimeter is known for its substantial investments in companies such as Snowflake, Uber, and Grab. The firm employs a growth-oriented investment strategy, often taking significant positions in companies with high potential for long-term growth. Altimeter manages a mix of hedge fund assets and private growth equity funds, with its public equity fund prominently featuring large holdings in technology giants like Meta, Amazon, and Nvidia. Altimeter Capital has made a total of 103 investments, including high-profile exits such as Snowflake, which provided a substantial return when it went public. Other notable investments include 23andMe, AppDynamics, and ByteDance​. The firm's investment activities are characterized by a strong emphasis on technology sectors, with significant allocations to cloud computing, fintech, and enterprise softwar. The firm is led by Brad Gerstner, who is well-regarded for his strategic insights and investment acumen. Altimeter's approach is to support visionary entrepreneurs who are transforming industries through innovation. This focus on transformative potential has made Altimeter a key player in the tech investment landscape, often participating in late-stage funding rounds and public offerings​. For startups and companies looking to engage with Altimeter, demonstrating robust growth potential and technological innovation is crucial. The firm's track record and strategic focus on impactful tech investments make it a significant force in the venture capital and hedge fund arenas​.

Altitude Ventures, commonly known as AV, is a venture capital firm focused on accelerating growth in healthcare services and digital health companies. Based in Nashville, Tennessee, and Houston, Texas, Altitude Ventures leverages its extensive industry experience and a deep network of healthcare professionals to provide more than just capital to its portfolio companies. The firm is particularly known for its hands-on approach, where they actively engage with partners to recruit talent, support operations, and provide strategic guidance. AV's investment strategy is centered around making early-stage investments, typically ranging from $2 million to $4 million, with a strong emphasis on maintaining significant stakes in its portfolio companies. The firm reserves a majority of its investable capital for follow-on investments, ensuring that companies have the necessary resources to scale through various growth stages. Founded on the legacy of the late Clayton McWhorter, a healthcare industry pioneer, Altitude Ventures continues to be guided by the principles of integrity and operational excellence that McWhorter championed throughout his career. The firm’s portfolio includes companies like Spiras Health, Mindoula, and Itiliti Health, all of which are innovators in the healthcare and digital health sectors. With over 50 years of collective experience in healthcare and investment, Altitude Ventures has built a robust network of payors, health systems, and providers, making it a key player in the healthcare venture capital space​.

Altius Venture Partners is a Mumbai, India-based early-stage venture capital fund founded in 2015, dedicated to backing gamechanging founders developing new innovations and disruptive business models. The firm operates as a mentor-led, methodology-driven platform, building an ecosystem of corporates, investors, mentors, and service providers around its portfolio companies. Co-Founder and General Partner Navyug previously co-founded QGLUE, India's first strategic design and innovation company, bringing a distinctive right-brain and left-brain perspective to investment evaluation. The team also includes investment professionals with backgrounds in transaction advisory and sector expertise spanning manufacturing, electric vehicles, and education. Altius leads seed and pre-seed rounds with check sizes of up to $500,000, targeting India-based startups across software, SaaS, fintech, healthtech, consumer goods, e-commerce, and adtech sectors. The portfolio of 11 companies includes 1 IPO and 3 acquisitions, a strong exit track record for a fund at this stage and check size. The firm deliberately seeks teams that haven't yet raised significant capital, favouring earlier entry and more meaningful ownership. Altius looks for intense founding teams solving large, hard problems — businesses with unique approaches that are tackling challenges significant enough to justify the difficulty of the venture path. The mentor-driven model means portfolio companies receive active support across commercial strategy, introductions, and operational guidance, not just capital. This approach reflects the firm's belief that the most impactful early-stage investors are those who combine financial commitment with genuine operating partnership through a startup's most difficult early phases.

Altos Ventures, founded in 1996 and based in Menlo Park, California, is a prominent venture capital firm managing over $10 billion in assets. Known for its early-stage investments, Altos Ventures focuses on consumer and enterprise technology companies. Some of their most notable investments include Coupang, Woowa Brothers, Roblox, and Toss, with Coupang achieving a valuation exceeding $100 billion at its IPO​. Altos Ventures typically makes initial investments ranging from $1 to $5 million, aiming to support the full lifecycle of their portfolio companies. They are known for their hands-on approach, providing significant operational support and partnering closely with management teams to build strong, scalable businesses​. Their investment strategy emphasizes strong operating fundamentals and attractive unit economics, targeting emerging opportunities in both the consumer and enterprise sectors. The firm has a significant presence in Asia, particularly in Korea and Japan, where they have successfully backed several unicorns​. Key figures at Altos Ventures include co-founders Han Kim and Ho Nam, who bring extensive experience and a deep understanding of the startup ecosystem. Startups seeking investment from Altos should demonstrate robust business models and the potential for long-term growth.

Purple Arch Ventures is a venture capital fund for alumni of Northwestern University and friends of the Northwestern community, based in Evanston, Illinois. Founded in 2017, it operates as part of the Alumni Ventures (AV) network — recognized as the most active venture firm in the United States and third globally by PitchBook in 2022, with more than $1 billion raised across 18 university-affiliated communities. The fund is now deploying its eighth annual vintage under Managing Partner David Beazley, a 25-year investment professional and Northwestern alumnus. Each annual fund constructs a diversified portfolio of 20 to 30 co-invested positions across SaaS, healthtech, fintech, AI, biotech, and clean technology, investing at Seed through Series C+ stages. Co-investors have included General Catalyst, Union Square Ventures, New Enterprise Associates, Founders Fund, Bessemer, Greylock, Lightspeed, and Y Combinator. Across 150 total investments to date, notable portfolio companies include Hopscotch Primary Care, Ion Storage Systems, Dimension Inx (3D-printed synthetic bone grafts), Epicore Biosystems (wearable electrolyte monitoring), and EarlyBird, a child-investing platform. The most recent disclosed exit was Prima in February 2025. Purple Arch offers members two paths into the portfolio: participation in the annual fund vehicle, which provides broad diversification with a single commitment, and deal-by-deal syndication access at low minimums for members who prefer direct exposure to individual opportunities. The fund's Northwestern connection requirement — founders, operators, or investors with university ties — creates a concentrated, high-signal deal network that the managing team uses to source alongside the nation's top-tier institutional co-investors.

Alven, founded in 2000 by Guillaume Aubin and Charles Letourneur, is a leading venture capital firm based in Paris with a strong focus on early-stage investments. The firm recently closed its sixth fund at €350 million, the largest early-stage fund raised in France, bringing their assets under management to €2 billion. Alven specializes in backing European entrepreneurs, with notable investments in companies like Qonto, Dataiku, Algolia, Stripe, and Ankorstore. The firm’s strategy includes investing between €100k and €15 million in seed and Series A rounds, with substantial reserves for follow-on investments. Alven supports its portfolio companies with an internal People Operations team, offering advisory services, access to talent pools, and resources to help them scale. The firm emphasizes a multi-sector specialist approach, focusing on fintech, marketplaces, enterprise software, social & entertainment, and emerging sectors like crypto and climate tech. Alven has realized more than 70 exits, including the recent sales of Sqreen to Datadog, Cardiologs to Philips, and Frichti to Gorillas. They recently expanded their geographic focus by opening a London office and continue to support European founders in the US. For startups looking to engage with Alven, it's crucial to demonstrate a strong growth potential and alignment with the firm’s commitment to long-term relationships and hands-on support​.

AM Ventures is a leading venture capital firm focused on the industrial 3D printing sector, also known as additive manufacturing. Established in Germany, AM Ventures supports early-stage startups worldwide that are innovating in areas such as materials, software, hardware, and applications related to 3D printing. The firm is renowned for its deep industry expertise and extensive global network, which spans 13 countries across four continents. The firm’s investment strategy is centered on empowering entrepreneurs who are developing next-generation technologies that can address major global challenges, including climate change, medical advancements, and digital manufacturing. AM Ventures typically invests between €500,000 and €3 million, focusing on companies from the seed stage to growth phases. In 2022, AM Ventures launched a €100 million venture capital fund dedicated to furthering its commitment to industrial 3D printing. This fund is the first of its kind, emphasizing the firm’s leadership in the additive manufacturing industry and its dedication to driving sustainable innovation on a global scale. The firm partners closely with its portfolio companies, offering not just financial backing but also strategic support and industry connections to help these startups thrive.

Amadeus Capital Partners, founded by Anne Glover and Hermann Hauser in 1997, is a renowned global technology investor. The firm has backed over 190 companies and raised more than $1 billion in investment capital. They focus on AI and machine learning, online consumer services, cyber security, digital health and medical technology, digital media, enterprise SaaS, fintech, regtech, and insurtech. Notable investments in their portfolio include Graphcore, FiveAI, Congenica, Sprout.ai, and Seldon. Amadeus follows a multi-faceted investment strategy: providing seed, start-up, and scale-up capital for early-stage companies in the UK, primary and secondary investments in high-growth tech companies in Europe, and growth capital for tech-enabled consumer and business services in emerging markets. They typically invest in companies with exceptional IP that have the potential to become global champions. With offices in Cambridge, London, San Francisco, and Cape Town, Amadeus Capital Partners supports scaling businesses with technical insight, operational experience, and access to a global network, including mentorship and non-executive directors. Their recent £110 million Amadeus V Technology Fund highlights their commitment to deep tech investment, with significant backing from British Patient Capital. Amadeus prefers to invest in companies that demonstrate a strong team, competitive edge, and the potential for global market impact. Founders should approach them with a well-articulated market opportunity and technological innovation to capture their interest.

Amasia, founded in 2013 by Ramanan Raghavendran and John Kim, is a venture capital firm based in Singapore with additional offices in Burlingame, California. The firm focuses on investments that drive behavior change towards sustainability and climate solutions. Their portfolio includes notable companies like Xendit, Go1, and Dialpad, highlighting their commitment to impactful tech ventures. Amasia invests primarily in seed to Series B stages across diverse sectors such as financial services, environmental tech, media, and entertainment. They have a global reach, investing in the United States, Southeast Asia, India, Europe, and Latin America. The firm’s strategy emphasizes investing in founders with global ambitions and providing them with access to global markets, best practices, and knowledge. With an average of four new investments annually, Amasia is known for its selective and focused approach. Their recent investments include Clarity, which raised $9.6 million in a Series A round, and Joro, which secured $10 million in a Series A round co-led by Amasia and Sequoia. The firm also co-invests with major players like Y Combinator and Sequoia Capital. Key team members include Wee Peng Yeo (Partner and CFO), Molly Wood (Venture Partner), and Sungwoo Kim (Venture Partner), with expertise spanning various sectors and geographies. Startups seeking investment should emphasize their alignment with Amasia’s mission for a safer and more sustainable planet and can approach the firm through warm introductions and a clear demonstration of their global impact potential. Amasia’s approach is defined by depth, curiosity, and a strong focus on founder relationships, ensuring meaningful and impactful engagements with their portfolio companies.

Amberstone Ventures is a San Francisco-based venture capital firm founded in 2019 with $50 million in assets under management, focused exclusively on investing in disruptive consumer product companies serving wellness needs for next-generation consumers and families. Managing Partner Alexander R. Bernstein and General Partners James Graham and Nicolas Mindel lead the five-person team, combining rigorous data-driven analysis with extensive consumer packaged goods experience to identify brand-first companies with genuine consumer resonance. The firm invests at pre-seed and seed stages with checks of $500,000 to $10 million, targeting companies with less than $15 million in trailing revenue and strong indicators of category leadership — authentic brand positioning, compelling revenue growth, healthy margins, and strong retail velocity. The portfolio of 13 companies includes Honey Mama's, JuneShine (hard kombucha), Clean Skin Club, and Bloom Nutrition. A second fund is actively investing, and Amberstone is targeting $90 million for its newest vehicle. Amberstone's investment thesis rests on the view that the next generation of dominant consumer brands will be built differently — with brand authenticity and community at the foundation rather than legacy distribution and mass marketing. The firm's approach combines the analytical rigour of quantitative data assessment with deep qualitative judgment about brand-market fit, allowing it to move decisively at the earliest stages when consumer momentum is first becoming visible in retail velocity, social media engagement, and repeat purchase behaviour.

Ambit Pragma Ventures is a Mumbai, India-based private equity firm founded in 2007, operating as Ambit Pragma Advisors LLP. The firm was established as India's first small cap growth and buyout PE fund, providing growth capital to small and medium enterprises with the potential to become sector leaders. Investment strategy centres on identifying companies with strong management teams and scalable business models across five sectors: entertainment and leisure, healthcare, logistics, consumer packaged goods, and infrastructure support services. Ambit Pragma deploys $3 million to $25 million per investment at Series A through growth stages, and leads rounds. The five-partner team brings operating DNA and decades of experience across their target domains. The portfolio of 9 companies has produced 5 acquisitions including Prime Focus Technologies, Vidal Healthcare, and Spear Logistics. The International Finance Corporation (IFC) has invested in Ambit Pragma II, providing institutional endorsement of the fund's approach and governance. Beyond capital, the firm takes a hands-on operational role with portfolio companies, providing strategic input, governance support, and the commercial relationships that come from decades of sector engagement across Indian industry. Ambit Pragma's long-standing SME focus differentiates it from the India VC mainstream, which has concentrated on consumer internet and software. The firm's conviction is that India's most durable value creation lies in building genuine sector leaders among the country's vast small-cap industrial and services base — businesses that generate real earnings and eventually attract either strategic acquirers or public market investors.

Amboy Street Ventures is the world's first venture capital fund focused exclusively on sexual health and women's health technology startups, founded in 2021 in Los Angeles, California. The firm closed a $20 million debut fund to invest in seed and Series A stage companies addressing a market opportunity of over $1 trillion in historically underfunded reproductive and women's health categories. Founder Carli Sapir, a former engineer turned investor, built the firm alongside General Partners Dominique Karetsos and Dr. Maria Godoy — both recognised leaders in the women's and sexual health industry. Amboy Street invests and leads rounds with checks of $100,000 to $2 million, targeting cutting-edge startups in fertility, menopause, maternal health, LGBTQ+ health, menstruation, hormonal health, sexual health, and contraception. The portfolio spans 28 investments across healthtech, biotech, and consumer products. The firm adds value beyond capital through a dedicated Value Enhancement Team that supports portfolio companies in marketing and branding, sales and distribution, and product development and scientific innovation. The firm's founding premise is that the systematic underfunding of women's and sexual health represents both a market inefficiency and a societal failure — and that specialised capital, combined with deep domain expertise and commercial networks within healthcare, consumer, and pharmaceutical channels, can correct both simultaneously. Amboy Street Ventures serves as a dedicated backer for founders building in categories that have long been considered taboo or peripheral by mainstream venture investors, despite serving billions of potential customers.

AME Cloud Ventures, founded by Yahoo! co-founder Jerry Yang, is a leading venture capital firm investing in data-driven companies. Notable investments include Zoom, Wish, Zymergen, Planet, and Freenome. The firm focuses on tech-heavy industries, particularly those involved in data infrastructure, applications, mobile, and sensors. AME Cloud Ventures operates globally with a strong emphasis on U.S. and China-based companies. Their strategy is to back visionary entrepreneurs, providing not just capital but also strategic guidance and a vast network of mentors and international partners. Their typical check size ranges from $2 million to $10 million for early-stage investments, with larger sums for later stages. They are known for their active role in portfolio companies, offering operational support and leveraging industry connections to foster growth and innovation. Key team members include Jerry Yang and Jeff Chung, who focus on empowering big thinkers and frontier technologies. The team, based in Palo Alto, California, includes experts in various fields such as manufacturing, biology, and intelligent robotics. Startups looking to engage with AME Cloud Ventures should seek introductions through their network and highlight how their innovative use of data aligns with AME's strategic vision. This, along with a strong business model and growth potential, increases the likelihood of securing investment from this influential fund

American Express, through its venture capital arm Amex Ventures, plays an active role in investing in innovative startups that align with its core business. Launched in 2011, Amex Ventures primarily focuses on companies developing cutting-edge technologies in sectors such as financial services, e-commerce, cybersecurity, and digital payments. The firm’s investment strategy centers around supporting companies that can help enhance and expand American Express's offerings, improve customer experience, and drive growth in key markets. Amex Ventures invests in early-stage to growth-stage startups that have the potential to shape the future of commerce. The venture arm has backed numerous successful companies, including Plaid, Stripe, Bill.com, and Trulioo, highlighting its emphasis on financial technology and innovation. By partnering with these startups, American Express gains access to new technologies that help improve its cardholder services, payment infrastructure, and digital offerings. In addition to providing capital, Amex Ventures offers its portfolio companies strategic guidance and access to its vast network of partners and customers. This allows startups to benefit from the global reach and resources of American Express while accelerating their own growth. The venture arm is integral to the company’s broader mission of remaining at the forefront of digital innovation in the financial industry. By fostering strong relationships with innovative startups, Amex Ventures helps American Express stay competitive in an evolving digital landscape, while also supporting the development of transformative technologies.

American Family Ventures (AFV) is an insurtech venture capital pioneer founded in 2010 as the corporate venture capital arm of American Family Insurance, one of the largest mutual insurance companies in the United States. Based in Madison, Wisconsin with a presence in New York, the firm manages $700 million or more in assets under management with a team of 24 including 4 partners. Limited partners represent $70 billion in premium, reflecting the scale of the institutional backing and commercial distribution available to the portfolio. AFV focuses on early-stage through growth-stage startups shaping the future of insurance and adjacent technology sectors. AFV invests from seed to growth stage with checks of $1 million to $20 million and leads rounds, with 102 total investments spanning fintech, software, AI, data analytics, cybersecurity, and healthtech. The portfolio includes 2 unicorns, 1 IPO, and 18 acquisitions. Notable portfolio companies include Life360 (family safety platform) and Ring Labs (smart home security, acquired by Amazon), alongside a broad set of insurtech innovators reshaping underwriting, distribution, claims, and customer engagement. As one of the earliest and most prolific corporate venture investors in the insurance technology space, AFV occupies a distinctive position — it combines the financial firepower of a major mutual insurer with a genuine venture discipline and a long track record of exits. Portfolio companies gain access to American Family's distribution channels, actuarial expertise, claims infrastructure, and agent network, creating commercial pathways into the insurance industry that independent founders would find extremely difficult to develop on their own.

Amgen Ventures is the corporate venture capital arm of Amgen Inc. (NASDAQ: AMGN), one of the world's largest biotechnology companies. Founded in 2004 and based in San Francisco — with additional offices in Seattle, Thousand Oaks, and Cambridge — the fund has invested over $1 billion across its 20-year history, backing early and later-stage biotech companies developing human therapeutics. Core therapeutic focus areas include oncology, inflammation, neuroscience, and cardiovascular disease. The fund deploys $2 to $3 million per transaction, with investments reaching up to $10 million per company across Seed through Series B rounds. With 80 investments spanning North America and Europe, Amgen Ventures supports novel modalities, platform technologies, and digital health solutions. The portfolio is led by Samantha Palmer, Executive Director and Head of Amgen Ventures, who was named to the 2024 Powerlist of 100 leading corporate venturing professionals. Amgen Ventures occupies a distinctive position in corporate venture: portfolio companies gain direct access to Amgen's extensive research capabilities, manufacturing infrastructure, and scientific expertise. In return, Amgen gains early visibility into external innovation across emerging therapeutic areas. This mutual exchange — strategic access for capital — underpins the fund's model, making it more than a financial investor and a genuine partner in building the next generation of biotech companies.

Amino Capital, based in Palo Alto, is a global venture capital firm focused on seed to growth-stage investments, with a particular emphasis on data-driven startups and technologies that create network effects. Founded by Larry Li, the firm manages over $1 billion in assets and has invested in a diverse array of sectors including Consumer Tech, PLG SaaS, Frontier Tech, AI, and Web3. Amino Capital's portfolio boasts over 200 companies, with notable investments in Chime, Webflow, Rippling, Grail, Weee!, Replit, and Turing. They have a track record of successful exits, with 25 exits and 17 companies achieving unicorn status. Their investment strategy centers on leveraging data moats to create sustainable competitive advantages for their portfolio companies. The firm is geographically focused primarily on the US, China, and parts of Europe, reflecting a broad international investment strategy. Their team, led by Larry Li and other experienced partners, provides significant value-add through strategic guidance, operational support, and extensive industry connections. For startups looking to engage with Amino Capital, the key is to demonstrate how their technology leverages data to create substantial network effects and competitive advantages. The firm looks for resilient and adaptable teams that can thrive in rapidly evolving tech environments. Larry Li, a former entrepreneur himself, emphasizes the importance of energetic and reflective teams in driving innovation.

Amino Collective is a Berlin-based venture capital firm with a primary focus on health and biotechnology. They specialize in backing early-stage ventures, especially those in the pre-seed to Series A stages, with investments ranging from $250,000 to $5 million. The firm is deeply committed to transforming healthcare through strategic partnerships with entrepreneurs and scientists who are pushing the boundaries of bio and health tech. Amino Collective's mission is to bring life-changing ideas to fruition, supporting founders who are "free and radical," unafraid to challenge established norms. The fund primarily targets European-based startups with the ambition to scale globally. Notable investments include Lindus Health, Molecule, and Nostos Genomics. Led by co-founders like Manuel Grossmann, Amino Collective is not just about providing capital but also about offering mentorship and fostering innovation in sectors like digital health, medical devices, and biotech. Their approach is focused on long-term impact, aiming to shape a better future by leveraging the latest advancements in science and technology.

Amity Ventures is a San Francisco-based venture capital firm that focuses on supporting founders in building category-defining businesses. Founded in 2016, the firm is committed to partnering with a select few startups, providing them with the necessary resources and guidance to scale effectively. The team at Amity Ventures includes experienced investors like Patrick Yang, a co-founder and general partner, and Peter Bell, a senior advisor with a notable history in early-stage investments and entrepreneurship. Amity Ventures' portfolio features a range of innovative companies across various sectors, including cybersecurity, contract management, communication software, and sales commissions management. Notable portfolio companies include Snyk, an application security provider; Evisort, an AI-powered contract management platform; Talkdesk, a cloud contact center solution; and CaptivateIQ, a sales commissions management platform. The firm emphasizes a collaborative approach, working closely with founders to help them build impactful technologies and scale their businesses. Their investment strategy focuses on early-stage technology companies, particularly those leveraging automation as a transformative force in their industries

AMOREPACIFIC Ventures is the corporate venture capital arm of AmorePacific Group, one of the world's leading beauty and cosmetics conglomerates, founded in Seoul in 1945. Established in 2011, the CVC operates from Seoul and focuses on innovative technologies across beauty, aesthetics, digital, and sustainability sectors throughout Asia. With iconic parent brands including Sulwhasoo, Laneige, and Innisfree, and a group revenue exceeding $5 billion, AmorePacific Ventures serves as a strategic gateway into the K-beauty and beauty-tech ecosystem. The firm invests primarily at seed and Series A stages in South Korean startups, writing checks of $500K to $3 million per transaction. The portfolio spans 22 companies across consumer goods, fashion, e-commerce, sustainability, and health and wellness. Chief Investment Officer Taehyung Kim leads the investment team, guiding a focused mandate aligned with the parent group's digital transformation and sustainability agenda. AMOREPACIFIC Ventures functions as a strategic intelligence unit as much as a financial investor, channeling capital into innovations that complement or extend AmorePacific Group's core product lines. Portfolio companies benefit from access to the group's formulation expertise, retail distribution across Asia, and deep understanding of the global beauty consumer — advantages that distinguish the CVC from generalist seed funds operating in the region.

Amplifier Ventures is a McLean, Virginia-based seed and early-stage venture capital firm founded in 2004, focused on technology companies in the Washington DC area. The firm concentrates on information technology and healthcare, backing founders at the pre-seed and seed stages with initial checks of $100K to $1 million. Since its founding, Amplifier has helped start 16 technology businesses and built a portfolio of 10 active companies. Investments range across software, health technology, and data sectors, with the most recent recorded investment in ArcheMedX, a healthcare technology company, in June 2017. The firm leads rounds, taking an engaged role with early-stage founders from the outset. The founders later established Amplifier Advisors, an innovation and economic development consulting practice that grew out of their experience operating the venture fund. Amplifier Ventures filled a meaningful gap in the DC-area startup ecosystem during a period when dedicated early-stage capital in the region was scarce. The firm's hands-on model prioritized close working relationships with founding teams, drawing on the partners' backgrounds in both technology and regional economic development. While investment activity has slowed in recent years, the portfolio reflects more than a decade of consistent support for emerging technology and healthcare companies across the mid-Atlantic.

Amplify Partners, founded in 2012 and headquartered in Menlo Park, California, is a venture capital firm specializing in early-stage investments. The firm focuses on areas such as information technology, machine intelligence, infrastructure, and developer tools, supporting technical founders building the next generation of applications and platforms. Amplify Partners has a notable portfolio, including investments in companies like Datadog, a leader in cloud monitoring and security; Fastly, a real-time content delivery network; and Scribe, which automates the documentation of processes. They have also invested in emerging startups such as Meroxa, a data streaming platform, and Metaphor, a search and discovery tool for data scientists. The firm has made over 258 investments, demonstrating a strong track record of identifying and nurturing innovative tech companies. Amplify Partners is also known for its significant exits, including Intellimize and Minerva Labs. Their investment approach combines providing capital with deep operational support, leveraging their extensive industry experience to help portfolio companies scale effectively. Amplify Partners recently expanded their Amplify Select Fund to $200 million, emphasizing their commitment to supporting their portfolio companies through various growth stages and into the public markets. This expansion allows them to double down on their most promising investments, ensuring sustained growth and success for their portfolio companies.

Amplify.LA, based in Los Angeles, is a pre-seed venture capital firm dedicated to supporting early-stage technology startups in the region. Founded in 2011, the firm has made over 150 investments and focuses on sectors such as enterprise software, fintech, consumer products, and healthtech. Notable investments in Amplify.LA’s portfolio include FloQast, an accounting workflow automation platform; Upwards, a technology-driven care solutions company; and Penelope, a retirement platform for small businesses. The firm has also seen successful exits, such as the acquisition of Lensabl, a direct-to-consumer optical company, and Clutter, a moving and storage service. Amplify.LA is known for its hands-on approach, providing not only capital but also strategic guidance and support to help startups grow and scale effectively. The team, led by co-founders Paul Bricault, Oded Noy, and others, leverages their extensive network and industry experience to drive the success of their portfolio companies.

Amplifyher Ventures, founded in 2018 and based in New York City, is a venture capital firm dedicated to investing in early-stage startups led by exceptional women. The fund's mission is to bridge the gender gap in leadership roles by supporting female founders and fostering diversity within the entrepreneurial ecosystem. Key investments include companies like Copper Cow Coffee, Expressable, and Summersalt, showcasing their focus on consumer products, e-commerce, and health tech. The firm emphasizes industries such as commerce, care, and connectivity, seeking out businesses that leverage community-driven marketing for exponential growth. Amplifyher Ventures typically invests in pre-seed, seed, and Series A rounds, with an average investment size of $2 million. Their strategic approach involves not just financial support but also leveraging their extensive network and marketing expertise to help startups scale efficiently without relying heavily on traditional advertising platforms like Facebook and Google. The team is led by Tricia Black, a seasoned venture capitalist with a background in high-growth business roles, and Meghan Cross, a former startup marketer and experienced VC. Both are based in New York and bring a wealth of experience in identifying and nurturing high-potential ventures. Amplifyher Ventures is known for its hands-on approach, actively engaging with portfolio companies to provide mentorship and strategic advice, thereby maximizing their chances of success​.

Amplitude Ventures is a Montreal-based venture capital firm, founded in 2018, that focuses on precision medicine, investing at the intersection of biology and AI. The firm aims to support and scale companies that drive significant advancements in healthcare, particularly within Canada's innovation-rich ecosystem. Notable investments include Zymeworks, a biopharmaceutical company specializing in protein therapeutics, which went public in 2017, and Milestone Pharmaceuticals, known for its treatment for cardiovascular conditions, which also went public in 2019. Other key investments are DrugBank, a comprehensive drug database, and Valence Labs, which was acquired by Recursion. Amplitude Ventures recently closed a $263 million fund, significantly enhancing their capacity to invest in and grow cutting-edge precision medicine companies. The firm operates with a hands-on approach, providing strategic guidance and leveraging a strong network of industry experts. The leadership team includes co-founders Dion Madsen, Jean-François Pariseau, and Bharat Srinivasa, who bring extensive experience in life sciences and venture capital, ensuring robust support for their portfolio companies.

Amplo, founded in 2017 and headquartered in Spring, Texas, is a global venture capital firm that invests in early-stage startups across various sectors, including financial technology, artificial intelligence, healthcare, and software. The firm has built an impressive portfolio with notable companies such as Robinhood, Parsley Health, and 1Concern. Amplo has successfully supported eight unicorns, including Genies, Ironclad, and TravelPerk, highlighting its strategic investment approach. The firm emphasizes backing companies that aim to create meaningful societal impact, reflecting its commitment to innovation and positive change. Recent investments include Crosby Health and Two Chairs, which focus on health tech and healthcare services, respectively. The team at Amplo is led by Sheel Tyle, the founder and CEO, and consists of experienced professionals dedicated to providing strategic support and resources to their portfolio companies.

Analytics Ventures, founded in 2016 and based in San Diego, is a unique venture studio that focuses on building and investing in early-stage companies powered by artificial intelligence (AI). The firm operates with the conviction that AI will be integral to every business sector, and it has positioned itself as a pioneer in this space by creating and nurturing startups within a collaborative studio environment. The firm invests primarily in industries like healthcare, enterprise applications, and financial services, with a special focus on AI-driven technologies. Notable portfolio companies include CureMatch, which develops decision-support systems for genomically matched cancer treatments, and CureMetrix, which offers FDA-approved AI technology for mammogram analysis. Analytics Ventures typically invests in seed-stage companies and takes a hands-on approach, working closely with founders to guide product development, go-to-market strategies, and scaling operations. The firm’s commitment to AI and its deep involvement in the ventures it supports make it a standout player in the venture capital landscape, particularly in the Southern California region.

Ananda Impact Ventures, established in 2009, is a leading European venture capital firm dedicated to impact investing. The firm operates primarily in the DACH region, the UK, Benelux, and Scandinavia, focusing on early-stage investments from Seed to Series A rounds. Ananda manages around €200 million in assets across multiple funds, including their latest €108 million fund launched in 2023. Ananda invests in companies that address significant social and environmental challenges, aligning their business models with the UN’s Sustainable Development Goals. Their portfolio includes companies like OroraTech, which uses satellite technology to monitor wildfires, and NatureMetrics, which provides biodiversity data solutions through eDNA technology. The firm's investment strategy is built on their unique Impact Termsheet, which ties financial success to measurable impact outcomes. This model ensures that the impact is integral to the business, fostering long-term sustainability and growth. Ananda also emphasizes diversity and founder health, supporting entrepreneurs with robust resources and a hands-on approach to partnership. Founders appreciate Ananda's supportive and mission-aligned investment approach, which combines financial backing with strategic guidance to help scale impactful innovations. The firm prides itself on its deep commitment to creating positive societal change through venture capital.

Anchor Capital GP, founded in 2019 and based in Dallas, Texas, is a venture capital firm that provides advisory services and investment capital for disruptive startups. The firm focuses on high-growth sectors like FinTech, PropTech, ClimateTech, and AdTech, with investments spanning from seed to Series D stages. Their portfolio includes notable companies like Prizeout, Nom Nom, and Plant Prefab, showcasing their interest in innovative businesses across industries. Anchor Capital GP’s approach leverages a robust network of private investors, family offices, and institutional partners to help startups scale globally. With 14 investments and 3 successful exits, the firm is actively involved in guiding startups through growth phases by providing capital, expertise, and strategic partnerships. They prioritize hands-on involvement, working closely with founders to ensure their companies succeed in the modern economy